These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1413082)

  • 1. Functional characterisation of alternatively spliced CD46 cytoplasmic tails.
    Russell SM; Loveland BE; Johnstone RW; Thorley BR; McKenzie IF
    Transplant Proc; 1992 Oct; 24(5):2329-30. PubMed ID: 1413082
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

  • 3. Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement.
    Liszewski MK; Atkinson JP
    J Immunol; 1996 Jun; 156(11):4415-21. PubMed ID: 8666815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of CD46 minigenes for the production of transgenic mice.
    Thorley BR; McInnes B; Christiansen D; McKenzie IF; Loveland BE
    Transplant Proc; 1995 Jun; 27(3):2177-8. PubMed ID: 7792924
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue-specific expression of CD46 isoforms.
    Johnstone RW; Russell SM; Loveland BE; Jayasuriya N; McKenzie IF
    Transplant Proc; 1992 Oct; 24(5):2331-2. PubMed ID: 1413083
    [No Abstract]   [Full Text] [Related]  

  • 6. Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains.
    Liszewski MK; Tedja I; Atkinson JP
    J Biol Chem; 1994 Apr; 269(14):10776-9. PubMed ID: 8144666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisense oligonucleotides decrease expression of human CD46, a regulator of complement.
    Milland J; Loveland BE; Russell SM; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2922-3. PubMed ID: 8212285
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function.
    Liszewski MK; Leung MK; Atkinson JP
    J Immunol; 1998 Oct; 161(7):3711-8. PubMed ID: 9759896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
    Anderson BD; Nakamura T; Russell SJ; Peng KW
    Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of CD46 polymorphic expression and demonstration of a protective role against lysis by xenosera.
    Loveland B; Russell S; Purcell D; Johnstone R; Thorley B; Sparrow R; McKenzie I
    Transplant Proc; 1992 Apr; 24(2):685-6. PubMed ID: 1632880
    [No Abstract]   [Full Text] [Related]  

  • 12. Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.
    Loveland BE; Szokolai K; Johnstone RW; McKenzie IF
    Transplant Proc; 1994 Jun; 26(3):1070-1. PubMed ID: 7518104
    [No Abstract]   [Full Text] [Related]  

  • 13. CD46 in Neisseria pathogenesis.
    Gill DB; Atkinson JP
    Trends Mol Med; 2004 Sep; 10(9):459-65. PubMed ID: 15350899
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis.
    Kojima A; Iwata K; Seya T; Matsumoto M; Ariga H; Atkinson JP; Nagasawa S
    J Immunol; 1993 Aug; 151(3):1519-27. PubMed ID: 8335944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells.
    Kirchner M; Heuer D; Meyer TF
    Infect Immun; 2005 May; 73(5):3072-82. PubMed ID: 15845515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans.
    Lozahic S; Christiansen D; Manié S; Gerlier D; Billard M; Boucheix C; Rubinstein E
    Eur J Immunol; 2000 Mar; 30(3):900-7. PubMed ID: 10741407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form.
    Hakulinen J; Junnikkala S; Sorsa T; Meri S
    Eur J Immunol; 2004 Sep; 34(9):2620-9. PubMed ID: 15307194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region.
    Nomura M; Kurita-Taniguchi M; Kondo K; Inoue N; Matsumoto M; Yamanishi K; Okabe M; Seya T
    Eur J Immunol; 2002 Oct; 32(10):2954-64. PubMed ID: 12355449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.